Preclinical studies were carried out at MD Anderson Cancer Center Orlando and published data1 from extensive testing of our topical and injectable formulations in small animal studies conducted demonstrate the following:
Projections by the clinical team at BioCurity are that the proposed formulations will have favorable stability profiles.
1 Baker, CH. Radiation Protection with Nanoparticles. JSM. Nanotechnology Nanomedicine 2(1):1019,2014